Latest Ratios: P/E Ratio -22.4x · EV/EBITDA 22.4x · ROE -5.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $15.2B | $16.6B | $10.1B | $17.0B | $25.5B | $27.2B | $15.8B | $7.8B | $8.4B | $14.4B | $9.7B |
| Enterprise Value | $16.9B | $18.3B | $12.5B | $20.4B | $27.4B | $29.3B | $18.7B | $10.3B | $9.6B | $15.1B | $9.8B |
| P/E Ratio → | -22.44 | — | — | 10.81 | 9.49 | 220.54 | 41.91 | 14.55 | 12.16 | 261.00 | 15.15 |
| P/S Ratio | 2.96 | 3.24 | 1.88 | 1.77 | 3.49 | 8.19 | 5.04 | 2.16 | 2.50 | 4.68 | 3.64 |
| P/B Ratio | 1.55 | 1.70 | 0.99 | 1.76 | 3.12 | 4.69 | 3.53 | 1.90 | 2.24 | 3.76 | 2.47 |
| P/FCF | 21.97 | 24.04 | — | — | 39.53 | — | — | — | — | — | 18.16 |
| P/OCF | 11.87 | 12.98 | 14.71 | 12.83 | 13.39 | 79.13 | 19.72 | 10.80 | 15.45 | 47.28 | 13.29 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.56 | 2.33 | 2.12 | 3.74 | 8.81 | 5.98 | 2.88 | 2.84 | 4.91 | 3.68 |
| EV / EBITDA | 22.40 | 24.29 | — | 30.41 | 9.76 | 37.28 | 24.68 | 11.50 | 10.36 | 18.39 | 13.38 |
| EV / EBIT | 180.14 | 195.40 | — | 84.63 | 10.94 | 55.05 | 35.57 | 15.09 | 13.23 | 24.21 | 19.32 |
| EV / FCF | — | 26.47 | — | — | 42.34 | — | — | — | — | — | 18.35 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.1% | 13.1% | 1.1% | 12.5% | 42.2% | 30.3% | 31.8% | 35.1% | 36.2% | 36.6% | 36.3% |
| Operating Margin | 1.8% | 1.8% | -11.8% | 2.5% | 34.2% | 16.0% | 16.8% | 19.1% | 21.5% | 20.3% | 19.0% |
| Net Profit Margin | -9.9% | -9.9% | -21.9% | 16.4% | 36.7% | 3.7% | 12.0% | 14.9% | 20.6% | 1.8% | 24.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -5.1% | -5.1% | -11.9% | 17.6% | 38.4% | 2.4% | 8.8% | 13.6% | 18.3% | 1.4% | 17.5% |
| ROA | -3.1% | -3.1% | -6.8% | 9.3% | 20.4% | 1.2% | 3.7% | 6.1% | 9.0% | 0.7% | 7.2% |
| ROIC | 0.6% | 0.6% | -3.7% | 1.6% | 21.0% | 5.2% | 5.6% | 8.9% | 11.5% | 10.9% | 6.9% |
| ROCE | 0.6% | 0.6% | -4.3% | 1.8% | 22.9% | 6.0% | 6.1% | 9.2% | 11.2% | 9.2% | 6.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.35 | 0.44 | 0.40 | 0.43 | 0.83 | 0.78 | 0.45 | 0.48 | 0.60 |
| Debt / EBITDA | 4.37 | 4.37 | — | 6.38 | 1.18 | 3.20 | 4.87 | 3.55 | 1.84 | 2.24 | 3.22 |
| Net Debt / Equity | — | 0.17 | 0.24 | 0.35 | 0.22 | 0.36 | 0.66 | 0.63 | 0.31 | 0.18 | 0.03 |
| Net Debt / EBITDA | 2.23 | 2.23 | — | 5.05 | 0.65 | 2.65 | 3.88 | 2.86 | 1.24 | 0.85 | 0.14 |
| Debt / FCF | — | 2.42 | — | — | 2.81 | — | — | — | — | — | 0.19 |
| Interest Coverage | 0.45 | 0.45 | -3.84 | 2.08 | 20.34 | 8.66 | 7.19 | 11.88 | 13.82 | 5.40 | 7.82 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.23 | 2.23 | 1.95 | 1.47 | 1.89 | 1.06 | 1.22 | 1.58 | 1.69 | 2.06 | 2.90 |
| Quick Ratio | 1.57 | 1.57 | 1.19 | 0.86 | 1.13 | 0.64 | 0.81 | 1.03 | 1.10 | 1.57 | 2.51 |
| Cash Ratio | 0.90 | 0.90 | 0.61 | 0.25 | 0.55 | 0.23 | 0.41 | 0.44 | 0.47 | 0.95 | 1.99 |
| Asset Turnover | — | 0.31 | 0.32 | 0.53 | 0.47 | 0.30 | 0.30 | 0.36 | 0.45 | 0.40 | 0.33 |
| Inventory Turnover | 3.79 | 3.79 | 3.54 | 3.89 | 2.04 | 2.90 | 2.84 | 3.03 | 3.07 | 3.29 | 3.79 |
| Days Sales Outstanding | — | 54.28 | 72.33 | 69.65 | 72.23 | 76.78 | 61.92 | 76.51 | 75.48 | 73.59 | 74.04 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.3% | 1.1% | 1.9% | 1.1% | 0.7% | 0.7% | 1.0% | 2.0% | 1.7% | 1.0% | 1.4% |
| Payout Ratio | — | — | — | 11.9% | 6.9% | 143.8% | 43.1% | 28.5% | 20.8% | 256.3% | 21.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 9.2% | 10.5% | 0.5% | 2.4% | 6.9% | 8.2% | 0.4% | 6.6% |
| FCF Yield | 4.6% | 4.2% | — | — | 2.5% | — | — | — | — | — | 5.5% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.9% | 1.7% | 0.0% |
| Total Shareholder Yield | 1.3% | 1.1% | 1.9% | 1.1% | 0.7% | 0.7% | 1.0% | 2.0% | 7.6% | 2.7% | 1.4% |
| Shares Outstanding | — | $118M | $118M | $118M | $118M | $117M | $107M | $106M | $109M | $112M | $113M |
Lithium price volatility exposure
Based on current market data, Albemarle's forward P/E of 10.80 suggests that investors are pricing in significant earnings recovery, yet the negative TTM P/E of -23.25 highlights the extreme volatility currently obscuring the company's true valuation relative to its historical specialty chemical peer group averages.
The current EV/EBITDA multiple of 23.13 appears elevated, likely reflecting the market's attempt to value the company through a trough in the commodity cycle. Investors should monitor whether this premium is justified by the long-term structural advantage of the company's brine assets or if it represents an overestimation of near-term earnings power.
As reported in recent financial statements, Albemarle's ROIC has struggled to maintain positive territory, bottoming at -5.3% in 2023Q4 before showing a modest recovery to 1.6% in 2026Q1, which underscores the difficulty of compounding returns during periods of severe lithium price compression.
The decay in ROIC suggests that the company's aggressive capital expenditure program has yet to yield the expected efficiency gains in the current pricing environment. This trend warrants further investigation into whether the recent capital allocation is truly value-accretive or if it is merely expanding capacity that remains underutilized.
According to quarterly data, the company's cash conversion cycle has fluctuated significantly, reaching a high of 142 days in 2025Q1, which indicates that Albemarle's ability to efficiently manage its inventory and receivables is currently hampered by the broader slowdown in lithium market demand.
The elevated days inventory outstanding, which peaked at 154 days in 2025Q1, suggests that the company is carrying significant stock that may be subject to further write-downs if market prices remain depressed. This inefficiency in working capital management directly impacts the company's liquidity and its ability to fund operations internally.
The most commonly misapplied metric for Albemarle is the simple P/E ratio, which fails to account for the significant non-cash charges and equity-method accounting noise that frequently distort the company's reported earnings during periods of rapid lithium price fluctuations.
Analysts should instead focus on EV/EBITDA or normalized free cash flow, as these metrics better capture the underlying operational performance of the Bromine and Catalyst segments. Relying on P/E ratios in this context obscures the true cash-generating floor provided by the company's non-lithium business units.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALB stock.
Albemarle Corporation's current P/E ratio is -22.4x. The historical average is 17.0x.
Albemarle Corporation's current EV/EBITDA is 22.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.3x.
Albemarle Corporation's return on equity (ROE) is -5.1%. The historical average is 14.5%.
Based on historical data, Albemarle Corporation is trading at a P/E of -22.4x. Compare with industry peers and growth rates for a complete picture.
Albemarle Corporation's current dividend yield is 1.25%.
Albemarle Corporation has 13.1% gross margin and 1.8% operating margin.
Albemarle Corporation's Debt/EBITDA ratio is 4.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.